Free Trial

CASI Pharmaceuticals (CASI) News Today

CASI Pharmaceuticals logo
$0.21 0.00 (0.00%)
As of 05/8/2026

CASI Latest News

CASI Pharmaceuticals Inc Valuation - Morningstar
Casi Pharmaceuticals reports Q3 EPS (55c) vs. (35c) last year
CASI Pharmaceuticals’ Mixed Third-Quarter Performance in 2024
BioInvent International AB (BIX0.DU)
CASI Pharmaceuticals, Inc. Q2 Loss Declines
Ligand Reports Second Quarter 2024 Financial Results
CASI Pharmaceuticals, Inc. (CASI)
CASI Pharmaceuticals updates on Juventas dispute
Recap: CASI Pharmaceuticals Q4 Earnings
CASI Apr 2024 2.500 call
Get CASI Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CASI and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CASI Media Mentions By Week

CASI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CASI
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

CASI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CASI Articles
This Week

0

1

CASI Articles
Average Week

Get the Latest News and Ratings for CASI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CASI Pharmaceuticals and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:CASI) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners